Pages that link to "Q41119149"

The following pages link to Inactivated poliovirus vaccine: past and present experience (Q41119149):

Displaying 39 items.

• Approved but non-funded vaccines: accessing individual protection (Q27022495) (← links)
• A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV) (Q27490876) (← links)
• Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40 (Q28392429) (← links)
• A high throughput combinatorial library technique for identifying formalin-sensitive epitopes (Q33261098) (← links)
• New technologies for making vaccines (Q33589117) (← links)
• Poliovirus immunizations. What goes around, comes around (Q33591555) (← links)
• Inactivation of respiratory syncytial virus by zinc finger reactive compounds. (Q33663190) (← links)
• Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins. (Q33784777) (← links)
• Neurovirulence of type 1 polioviruses isolated from sewage in Japan. (Q34096876) (← links)
• Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge (Q34244892) (← links)
• Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis (Q34342694) (← links)
• Estimating the risk of re-emergence after stopping polio vaccination (Q36078628) (← links)
• Human leukocyte antigen polymorphisms: variable humoral immune responses to viral vaccines (Q36383797) (← links)
• Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies (Q36713884) (← links)
• Inactivated polio vaccine: its proposed role in the final stages of polio eradication (Q36878782) (← links)
• Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine (Q36899024) (← links)
• World wide experience with inactivated poliovirus vaccine (Q37235471) (← links)
• Correlates of protection induced by vaccination (Q37750121) (← links)
• Models of RNA virus evolution and their roles in vaccine design (Q37808509) (← links)
• Expert review on poliovirus immunity and transmission (Q38026922) (← links)
• Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis (Q38028997) (← links)
• Combined immunodeficiency presenting with vaccine-associated paralytic poliomyelitis: a case report and narrative review of literature. (Q38167805) (← links)
• Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame. (Q38544598) (← links)
• Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge (Q40562925) (← links)
• Oral poliomyelitis vaccine: time to change? (Q40718622) (← links)
• Rare adverse events associated with oral poliovirus vaccine in Brazil (Q41590617) (← links)
• Misconceptions about the new combination vaccine (Q42386505) (← links)
• Identification of formaldehyde-induced modifications in proteins: reactions with model peptides (Q44669066) (← links)
• New chemical method of viral inactivation for vaccine development based on membrane fusion inhibition (Q46940625) (← links)
• Green Tea Catechin-Inactivated Viral Vaccine Platform (Q47556992) (← links)
• Production and Characterization of Chemically Inactivated Genetically Engineered Clostridium difficile Toxoids (Q51314343) (← links)
• Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis (Q57108390) (← links)
• DTPa-HBV-IPV vaccine for primary vaccination of infants (Q57588912) (← links)
• Immune Priming and Long-term Persistence of Memory B Cells After Inactivated Poliovirus Vaccine in Macaque Models: Support for at least 2 Doses (Q58094238) (← links)
• Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules (Q73133107) (← links)
• Controversies in polio immunization (Q73858809) (← links)
• Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection (Q84059759) (← links)
• Rapid development of an inactivated vaccine candidate for SARS-CoV-2 (Q94589803) (← links)
• Immunological considerations for COVID-19 vaccine strategies (Q98952103) (← links)